Find out about our clinical trials process, how we work with doctors and volunteers throughout this process, and how to become a research volunteer.

GSK Product Testing

Our Study Register

The GSK Global Study Register provides information on our studies. This supplements information presented in scientific journals, at scientific congresses, in letters to healthcare professionals, and in approved prescribing information. We aim to publish our clinical research of our investigational products as papers in the scientific literature.

We believe that all those involved in the conduct and publication of clinical research have a role to play in ensuring that information from clinical trials is made publicly available.

Clinical Research Volunteer

Become a clinical research volunteer

Everyone who takes part in a clinical trial is a volunteer, regardless of whether they are healthy or have been diagnosed with the condition the trial aims to treat. If you would like to register as a potential healthy trial volunteer for studies run directly by GSK in the UK, please visit our Global GSK clinical trials website.

For all other studies, please ask your doctor whether there are any clinical studies ongoing that may be suitable for you.

Global Compassionate use policies and programmes

Clinical trial diversity

We want our clinical trials to be as representative and accessible as possible, reflecting patient populations experiencing the disease and including age, race, ethnicity, sex and gender.

Over the past five years, we have worked hard to improve patient diversity in our clinical trials by implementing training and support to personnel at investigator sites, including awareness training on conducting clinical trials in underserved communities.

In 2021, we formed a Global Demographics and Diversity team to better coordinate our learning about epidemiology, burden of disease and health equity, and how they relate to age, sex, gender, race and ethnicity so we can apply these lessons when planning our trials.

Global Diversity in clinical trials